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Autophagy is a self-degradative process involved both in basal
turnover of cellular components and in response to nutrient star-
vation or organelle damage in a wide range of eukaryotes1–3.
During autophagy, portions of the cytoplasm are sequestered by
double-membraned vesicles called autophagosomes, and are
degraded after fusion with lysosomes for subsequent recycling4.
In vertebrates, this process acts as a pro-survival or pro-death
mechanism in different physiological and pathological conditions,
such as neurodegeneration and cancer2,5–7; however, the roles of
autophagy during embryonic development are still largely unchar-
acterized3. Beclin1 (Becn1; coiled-coil, myosin-like BCL2-interact-
ing protein) is a principal regulator in autophagosome formation,
and its deficiency results in early embryonic lethality8,9. Here we
show that Ambra1 (activating molecule in Beclin1-regulated
autophagy), a large, previously unknown protein bearing a
WD40 domain at its amino terminus, regulates autophagy and
has a crucial role in embryogenesis. We found that Ambra1 is a
positive regulator of the Becn1-dependent programme of autop-
hagy, as revealed by its overexpression and by RNA interference
experiments in vitro. Notably, Ambra1 functional deficiency in
mouse embryos leads to severe neural tube defects associated with
autophagy impairment, accumulation of ubiquitinated proteins,
unbalanced cell proliferation and excessive apoptotic cell death. In
addition to identifying a new and essential element regulating the
autophagy programme, our results provide in vivo evidence sup-
porting the existence of a complex interplay between autophagy,
cell growth and cell death required for neural development in
mammals.
Autophagy is a highly regulated mechanism, as demonstrated by
the identification of several autophagy-related (Atg) genes in the
yeast Saccharomyces cerevisiae10. Recent studies have not only demon-
strated the evolutionary conservation of Atg function in vertebrates
but also highlighted the involvement of the autophagic machinery in
many aspects of tissue homeostasis2,3. Indeed, autophagy has a pro-
tective function against the onset of neurodegeneration5,6 and the
alteration of cell growth in cancer7,9,11. Moreover, a complex inter-
action between the pathways of autophagy and apoptosis has been
reported in several in vitro systems, in which dysregulation of the
apoptotic pathway induces changes to the autophagy programme
and vice versa12–15.
A role of autophagy in the regulation of vertebrate development
has long been proposed by studies reporting morphological features
of autophagy during embryogenesis3,16–18. Targeted mutagenesis of a
few Atg genes in mice substantiated this hypothesis. Embryos that
contain a mutation to Becn1, the orthologue of yeast Atg6, die early
during embryogenesis, exhibiting a developmental delay9, whereas
Atg5- or Atg7-deficient mice survive embryogenesis but suffer
from nutrient and energy insufficiency soon after birth19,20. In addi-
tion, Atg52/2 embryos were shown to have deficient autophagy-
dependent clearance of apoptotic cell corpses during development21.
However, it is not yet known how autophagy can be regulated during
development, and whether vertebrate-specific factors besides the Atg
genes have a role in this context.
Using a large-scale mutagenesis approach based on gene trapping
inmice22, we isolated a novel gene involved in the development of the
nervous system. This gene encodes a 1,300-amino-acid-long WD40
protein that is highly conserved in vertebrates (Supplementary Fig.
1). We named this protein Ambra1 because of its functions, as
described below. In embryos homozygous for the gene-trapped allele
(Ambra1gt/gt) we revealed a fusion transcript (trapped gene-lacZ) and
its corresponding protein, whereas the endogenous protein was
absent (Fig. 1a, b). Because b-galactosidase (b-gal) activity in a gene-
trap line mimics the expression of the tagged endogenous gene23, we
performed Ambra1 expression analysis after whole-mount b-gal
staining in heterozygous embryos throughout development and in
postnatal brain (see Fig. 1c–e and Supplementary Fig. 2). At embry-
onic day (E)8.5, strong staining was detected throughout the neuro-
epithelium (Fig. 1c and Supplementary Fig. 2a). At E11.5 (Fig. 1d, e),
a robust expression was seen in the ventral-most part of the spinal
cord, the encephalic vesicles, the neural retina, the limbs and the
dorsal root ganglia. Messenger RNA in situ hybridization using an
Ambra1 probe confirmed the expression pattern (Fig. 1f and Supple-
mentary Fig. 2b, compared with b-gal staining in Supplementary Fig.
2c). At later developmental stages, the b-gal staining became abund-
ant in the entire developing nervous system as well as in other tissues
(Supplementary Fig. 2d); strong expression was observed in the cor-
tex, hippocampus and striatum of postnatal brain (Supplementary
Fig. 2e–i).
Notably, we found that homozygosity of the Ambra1 mutation
causes embryonic lethality in outbred or inbred genetic backgrounds
(Supplementary Table 1). Most Ambra1gt/gt embryos at stages E10–
E14.5 exhibit neural tube defects detected as midbrain/hindbrain
exencephaly and/or spina bifida (Fig. 1g–j). Histological analysis
revealed that, in the embryonic forebrain of Ambra1gt/gt mice, the
vesicles are closed but displaced, the proliferative neuroepithelium
shows an extensive overgrowth and the spinal cord is enlarged
(Fig. 1k, l). Next, we performed a detailed analysis of cell death,
differentiation and growth in Ambra1gt/gt embryos. Excessive
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apoptosis was present in selected areas of the mutant nervous system
from E9.0 onwards (Fig. 1m–p, Supplementary Fig. 3 and data not
shown). We then observed that patterning regulators, such as Shh,
Fgf8, En1, En2, Gli3, Pax2, Pax3, Pax5, Pax6, Ngn2 (also called
Neurog2), Dlx1, Dlx2 and Mash1 (Ascl1), are present at wild-type
levels in the developing mutant brain and spinal cord, although a few
of them are displaced or show decreased expression (Supplementary
Fig. 4 and data not shown). Finally, 5-bromodeoxyuridine (BrdU)-
uptake experiments and measurement of mitoses revealed a statist-
ically significant increase of proliferating cells in Ambra1gt/gt E8.5
neural folds (Fig. 1q, r and Supplementary Fig. 5a, b). However, from
E9.5 onwards, the percentage of BrdU-positive cells out of the total
number of cells was similar between the mutant and wild-type
neuroepithelium, indicating that the hyperproliferation phenotype
appears at the onset of neurulation (Fig. 1s, t and Supplementary Fig.
5a). Taken together, these results indicate thatAmbra1 is necessary to
control cell proliferation and to guarantee cell survival during nerv-
ous system development.
To define the biological processes regulated by Ambra1, we iden-
tified its molecular interactors using a yeast two-hybrid approach.
Complementary DNA encoding the first 667 amino acids of the
human AMBRA1 orthologue (Supplementary Fig. 1c) was used to
screen a human brain cDNA expression library. One of the isolated
clones (Fig. 2a) encodes the Atg protein BECN1, a component of the
class III phosphatidylinositol-3-OH kinase (also known as Vps34)
complex regulating autophagosome formation in mammals8,24.
The BECN1–AMBRA1 interaction was confirmed in co-transduced
human 2FTGH fibroblasts by co-immunoprecipitation assays (Fig.
2b, c). To map the region responsible for BECN1 binding, we tested
different AMBRA1 mutant constructs in co-immunoprecipitation
with BECN1. A central region of the protein (F2) is necessary and
sufficient for an effective interaction with BECN1, whereas the
AMBRA1 amino terminus (F1) shows a minimal binding capability,
and its carboxy terminus (F3) does not interact at all (Fig. 2b). The
BECN1-associated kinase Vps34 co-immunoprecipitates with
AMBRA1, suggesting that BECN1, Vps34 and AMBRA1 are compo-
nents of a multiprotein complex (Fig. 2c). The BECN1–AMBRA1
interaction was also confirmed in developing brain samples by co-
immunoprecipitating the endogenous proteins (Fig. 2d). Consistent
with their interaction, BECN1 and AMBRA1 showed a vesicular-like
staining that mostly co-localized in 2FTGH cells (Fig. 2e).
The BECN1–AMBRA1 interaction prompted us to test for a pos-
sible role of AMBRA1 in autophagy regulation. The occurrence of
autophagy was analysed in 2FTGH cells by assessing both conversion
of microtubule-associated protein 1 light-chain 3 (LC3)-I to LC3-II
and its translocation to autophagic structures—two sequential
steps in autophagosome formation25. First we tested the cell response
to two autophagic stimuli—the mTOR (mammalian target of
rapamycin)-inhibitor rapamycin and nutrient deprivation—upon
reduction of AMBRA1 levels by RNA interference. Downregulation
of AMBRA1 (Fig. 3a) resulted in a remarkable decrease in autophagy
(Fig. 3b, c and Supplementary Fig. 6a). Because BECN1 overexpres-
sion has been shown to induce autophagy per se8, we tested the effect
of AMBRA1 overexpression on autophagy either at basal levels or
in rapamycin-treated 2FTGH cells. A significant increase of both
basal and rapamycin-induced autophagy was observed (Fig. 3d).
Furthermore, we checked whether interaction with BECN1 was
required for AMBRA1-induced autophagy by using AMBRA1 F1,















































Figure 1 | Neural tube defects in Ambra1 mutant embryos. a, Detection of
wild-type (1) and Ambra1 gene-trap transcripts (gt) from total E14.5
embryos analysed by northern blotting. Size marker, 28S ribosomal RNA.
b, Immunoblot analysis of E14.5 embryo brain extracts using antibodies
against Ambra1 (left panel) and b-gal (right panel). Specific bands
(arrowheads) and unspecific signals (asterisk) are indicated. Molecular
weights are measured in kilodaltons (kDa). The fusion protein can be
revealed only by means of the more sensitive anti-b-gal antibody.
c–f, Expression of Ambra1 in the mouse embryonic nervous system. b-gal-
staining on whole-mount Ambra11/gt mouse embryos at E8.5 (c), E11.5
(d) and on a cross-section of E11.5 spinal cord (e) is shown. Fb, forebrain;
Hb, hindbrain; Mb, midbrain. f, Matching expression of the endogenous
gene was revealed by whole-mount Ambra1 mRNA in situ hybridization
analysis in E11.5 wild-type embryos. g–l, Electron scanning microscopy
analysis of E11.5 (g) and E12.5 (h) Ambra1gt/gt embryos. Note the failure of
the neural tube closure, the extensive midbrain/hindbrain exencephaly (Ex)
with a closed telencephalon (T), and the lumbosacral spina bifida (Sb).
i, j, E14.5 wild-type (i) and Ambra1gt/gt (j) embryos are characterized by
prominent exencephaly. k, l, Histological analysis of E12.5 wild-type (k) and
Ambra1gt/gt (l) embryos on cross-section. Note the absence of a normal
ventricular system, the extensive overgrowth of the proliferative
neuroepithelium in the diencephalon (Di) and spinal cord (Sc), and the
enlarged fifth ganglia (VG) in the Ambra1gt/gt embryo. m–p, TUNEL (TdT-
mediated dUTP nick end labelling) staining of E10.5 brain (m, n) and E9.5
spinal cord (o, p) in wild-type (m, o) and Ambra1gt/gt (n, p) embryo sections.
q–t, Analysis of cell proliferation in wild-type (q, s) and Ambra1gt/gt
(r, t) embryos on transverse sections of E8.5 cephalic neural folds in
prospective hindbrain region (mitoses, arrows in q, r) and on sagittal
sections of E10.5 forebrain (BrdU uptake, s, t). Scale bars: c, g, h, k, 500mm;
d, 1mm; e, 150mm; i, 2mm; m, s, 400mm; o, 78mm; and q, 50mm.
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Figure 3 | AMBRA1 regulates autophagy. a, AMBRA1 downregulation in
2FTGH cells using specific short interfering RNA (siRNA)
oligoribonucleotides (1 and 2). AMBRA1 mRNA and protein levels were
analysed by quantitative polymerase chain reaction (PCR, left) and western
blotting (right), respectively. An unrelated oligoribonucleotide was used as
the control. Tubulin was used as the protein-loading control. RL, relative
levels. The arrowhead indicates the AMBRA1-specific band. b, Rapamycin-
induced autophagy requires AMBRA1. After AMBRA1 downregulation,
2FTGH cells were treated with rapamycin; after 48 h, the occurrence of
autophagy was analysed by appearance of GFP–LC3 punctate staining or by
LC3-I to LC3-II conversion (western blot in inset). Representative results are
accompanied by a graph reporting data from three experiments. Scale bar,
20mm. c, Nutrient-starvation-induced autophagy requires AMBRA1. After
AMBRA1 downregulation, 2FTGH cells were starved for 4 h and analysed for
appearance of GFP–LC3 punctate staining. d, AMBRA1 overexpression
increases basal and rapamycin-induced autophagy. 2FTGH cells were
transduced with full-length AMBRA1 (FL), AMBRA1 fragments (F1–3),
BECN1 and b-gal (negative control) encoding retroviruses. They were then
stimulated with rapamycin or left untreated, and analysed by appearance of
GFP–LC3 punctate staining. e, BECN1-induced autophagy requires
AMBRA1. After AMBRA1 downregulation, GFP–LC3-expressing 2FTGH
cells were transduced with a BECN1-encoding retrovirus. Occurrence of
autophagy was analysed 48h later by appearance of GFP–LC3 punctate
staining. f, AMBRA1 downregulation reduces the amount of Vps34
associated to BECN1 during autophagy. Forty-eight hours after AMBRA1
downregulation with oligo 2, 2FTGH cells were either starved or cultured in
standard medium for an additional 4 h. Protein extracts were
immunoprecipitated (IP) using an anti-BECN1antibody. Purified complexes
and corresponding total extracts were analysed by western blotting with anti-
Vps34 (left panels) and anti-BECN1 (right panels) antibodies. The graph
indicates the signal intensity of BECN1-associated Vps34 as determined by
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Figure 2 | AMBRA1 is a novel BECN1-interacting protein.
a, AMBRA1–BECN1 interaction by yeast two-hybrid assay. Yeast cells were
co-transfected with the indicated plasmids and plated in medium with (1)
or without (–) histidine (H) and adenine (A). AD, activation domain; DBD,
DNA-binding domain; G4, Gal4; LAM, lamin. b, AMBRA1–BECN1
interaction inmammalian cells. 2FTGHcells were co-infectedwith retroviral
vectors encoding BECN1 and the indicated Myc-tagged AMBRA1 proteins,
or Myc-tagged b-gal as a negative control. CT, C terminal; FL, full length;
NT, N terminal. Protein extracts were immunoprecipitated using an anti-
Myc-tagged antibody (IPMyc). Purified complexes and corresponding total
extracts were analysed by western blot using anti-Myc (WB Myc, upper
panels) or anti-BECN1 (WB BECN1, lower panels) antibodies. When
multiple bands are present, the upper band has the expectedmolecularmass.
A scheme of the various AMBRA1 mutants is reported. c, AMBRA1 is in a
complex that includes BECN1 andVps34. Protein extracts from2FTGHcells
co-expressing BECN1 and theMyc-taggedAMBRA1 full-length protein (FL)
or Myc-tagged b-gal were immunoprecipitated using an anti-Myc-tag
antibody (IP Myc). Purified complexes and corresponding total extracts
were analysed using anti-BECN1 (WB BECN1) and anti-Vps34 (WBVps34)
antibodies. d, AMBRA1–BECN1 interaction in developing brain tissues.
Protein extracts from two E14.5 wild-type brains (A and B) were
immunoprecipitated using an anti-AMBRA1 antibody (AMBRA1) or the
pre-immune serum (Pre). Purified complexes and corresponding total
extracts were analysed using anti-AMBRA1 (WB AMBRA1) and anti-
BECN1 (WB BECN1) antibodies. The asterisk indicates the position of co-
migrating immunoglobulins. e, BECN1 and AMBRA1 co-localize in
mammalian cells. 2FTGH cells co-expressing BECN1 and Myc-tagged
AMBRA1 were stained for Myc (green) and BECN1 (red). Scale bars, 8mm.
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at levels similar to the full-length AMBRA1, F3 had no detectable
effect (Fig. 3d), whereas F1 showed an intermediate effect, probably
because of its residual BECN1-binding capability. The effects of
AMBRA1 dysregulation on the autophagy process were confirmed
by measurement of the formation of acidic vesicular organelles26
(Supplementary Fig. 6b, c). Also we observed that BECN1-mediated
induction of autophagy wasmarkedly reduced after AMBRA1 down-
regulation (Fig. 3e). Consistently, we showed that AMBRA1 down-
regulation leads to a reduced capability of BECN1 to interact with its
associated kinase Vps34, and to a decrease in Vps34 activity in cells in
which autophagy has been induced (Fig. 3f and Supplementary Fig.
6d–f). This finding suggests a role for AMBRA1 in favouring the
BECN1–Vps34 functional interaction. Taken together, these results
show that AMBRA1 is a key factor in autophagy regulation and is
required for BECN1 activity.
The autophagy-promoting activity of BECN1 has been associated
with inhibition of cell proliferation8. Given the observed hyperpro-
liferative phenotype in Ambra1 mutant embryos (see Fig. 1q–t and
Supplementary Fig. 5), we investigated whether AMBRA1 dosage is
critical for cell growth control in vitro. AMBRA1 downregulation or
its overexpression resulted in a significant increase or decrease of cell
proliferation rate, respectively (Supplementary Fig. 7a, b).Moreover,
inhibition of proliferation by AMBRA1 is dependent on BECN1, as
this effect is abolished when BECN1 is downregulated (Supple-
mentary Fig. 7c). These observations support the view that dysregu-
lation of BECN1-dependent autophagy is linked to abnormal cell
proliferation.
On the basis of these in vitro results, we investigated whether
autophagy defects were detectable in Ambra1 mutants. Conversion
of LC3-I to LC3-II was markedly reduced in Ambra1gt/gt E14.5
embryos (Fig. 4a, left panel). LC3 translocation was analysed by
crossing Ambra11/gt mice with transgenic mice ubiquitously expres-
sing green fluorescent protein (GFP)–LC3 (ref. 27). Fluorescence
microscopy examination of E10.5 neuroepithelium showed clusters
of GFP–LC3 dots in wild-type embryos, whereas a diffuse signal was
detectable in Ambra1gt/gt littermates (Fig. 4a, right panels). Next,
because autophagy impairment in the adult nervous system is accom-
panied by accumulation of ubiquinated proteins5,6, we checked for
ubiquitin expression in developing brains of Ambra1gt/gt embryos.
Numerous ubiquitin-positive cells were present in the mutant
neuroepithelium, with a predominant nuclear staining (Fig. 4b).
Furthermore, autophagy defects were confirmed in Ambra1gt/gt
mouse embryonic fibroblasts, as revealed by GFP–LC3 translocation
to autophagosomal membranes, ultrastructural analysis and mea-
surement of formation of acidic vesicular organelles (Fig. 4c, d,
Supplementary Fig. 8a–c). Finally, a reduction in the activity of the
mutant Ambra1 protein present in the Ambra1gt/gt mice, in terms of
the capability to both interact with Becn1 and induce autophagy, was
confirmed by transfection experiments using a construct mimicking
the mutant fusion mRNA (Supplementary Fig. 8d, e). Thus, we con-
clude that theAmbra1 gene-trap allele carries a loss-of-functionmuta-
tion that causes a severe autophagy defect in Ambra1gt/gt embryos.
Here we show that deficiency of Ambra1, a novel Becn1 partner
mainly expressed in the neural tube during development, impairs
autophagy and results in severe neural tube defects. Besides the putat-
ive role of AMBRA1 in human congenital brain malformation, its
expression profile in adult brain compartments, which are affected
in patients with neurodegenerative disorders (Supplementary Fig. 2),
suggests a role for AMBRA1 in these diseases, as already shown for
other autophagy regulators5,6.
Morphogenesis of the nervous system is based on a complex inter-
play between the control of balanced cell proliferation, differenti-
ation and apoptosis28. Our finding that the level of ubiquitinated
proteins is markedly enhanced in Ambra1 mutant neuroepithelium
implies a role for autophagy-dependent protein turnover in the con-
trol of neural development. A sensitive balance of degradation of key
neurodevelopmental regulators might be hypothesized as having a
role in the determination of cell fate and, when altered, may lead
per se to the observed neural tube defects. Alternatively, such a
phenotype might be the consequence of disturbed cell proliferation
and apoptosis, caused by autophagy dysregulation. In fact, Ambra1
deficiency during embryogenesis leads to excessive cell proliferation
at early stages followed by increased apoptosis in the neuroepithe-
lium. Genetic evidence that autophagy controls cell proliferation was













































































Figure 4 | Autophagy is impaired inAmbra1mutant embryos. a, Alteration
of both LC3 conversion and translocation in Ambra1gt/gt embryos. Left
panel: immunoblot analysis of LC3 in E14.5 embryos. LC3-I to LC3-II
conversion is reduced in mutant extracts (LC3-II/LC3-I ratio, as measured
by densitometry, from left to right: 5%, 9.8%, 2.5%, 4.6%). B, body; H, head.
Centre and right panels: sections from E10.5 Ambra11/1;GFP–LC3 and
Ambra1gt/gt;GFP–LC3 neuroepithelia were compared to evaluate GFP–LC3
subcellular distribution. Clusters of GFP–LC3 punctate structures (arrows)
are indicated in wild-type sections. Images were optimized by
deconvolution. Scale bar, 10 mm. b, Ubiquitin-positive cells in developing
brains of Ambra1gt/gt embryos. Sagittal sections from E11.5 embryos were
stained using an anti-ubiquitin antibody. Ubiquitin accumulates in
numerous mutant neuroepithelial cells (shown at different magnification:
upper panels, scale bar, 25mm; lower panels, scale bar, 10 mm). Ambra1
mutant protein is visualized in the left panels by b-gal activity (light-blue
staining). Counterstaining, haematoxylin blue. c, Rapamycin-induced
autophagy is impaired inAmbra1gt/gt murine embryonic fibroblasts (MEFs).
Cells dissected from embryos with different genotypes (A–D) were treated
with rapamycin, and the occurrence of autophagy was analysed 48 h later by
the appearance of GFP–LC3 punctate staining. Representative results are
shown in the upper panels, whereas the lower panel shows the data from
three experiments. Scale bar, 20mm. d, Ultrastructural analysis by means of
electron microscopy of ultrathin sections from wild-type and Ambra1gt/gt
cultured MEFs. The arrows indicate autophagic vacuoles. Scale bar, 1.5 mm.
Quantification of the mean number of autophagic vacuoles per cell in wild-
type and Ambra1gt/gt cultured MEFs is shown in the graph. Values in c and
d represent the mean6 s.d. of three experiments.
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interactor ultraviolet radiation resistance associated gene (UVRAG)
8,9,11,29. Our results suggest that the excessive cell proliferation in the
Ambra1 mutant is directly associated with Becn1 dysregulation.
However, we cannot rule out that neuroepithelial cells deficient in
autophagy undergo apoptosis in a cell-autonomous fashion, whereas
the surrounding cells, lacking proper signalling (for example, Shh-
mediated mitogenic induction), overproliferate.
The identification of a vertebrate-specific autophagy regulator
that is active in an evolutionarily conserved pathway opens up a
new scenario involving autophagy in specialized roles during the
development of higher eukaryotes.
METHODS SUMMARY
Generation of Ambra1gt/gt mice. The embryonic stem cell line containing an
insertion of the gene-trap vector pGT1.8geo (a gift fromW. Skarnes)23 within the
Ambra1 gene was generated as described22. Founder chimaericmales weremated
with outbred NMRI females, and heterozygous progenies were mated to main-
tain the allele. Also, backcrossing with C57BL/6 males was carried out to obtain
an inbred strain. In some experiments, GFP–LC3 mice27 were crossed with
Ambra11/gt mice to generate Ambra11/gt;GFP–LC3 mice. The latter were then
crossed with each other to obtain Ambra1gt/gt;GFP–LC3 embryos.
Autophagy assays. Autophagy was measured in GFP–LC3 transduced cells as
described30. Briefly, cells grown on coverslips were fixed with 4% paraformalde-
hyde in PBS, washed three times and directly examined by confocal microscopy.
The results indicate the percentage of GFP–LC3-positive cells with GFP–LC3
punctate dots. Aminimumof 50–100 cells per samplewere counted for triplicate
samples per condition per experiment.
To quantify the development of acidic vesicular organelles26, cells were
detached by trypsin digestion, washed with PBS, stained with acridine orange
(1mgml–1; Sigma–Aldrich) for 15min and analysed using a FACScan flow cyto-
meter (Becton Dickinson) and CellQuest software. For electron microscopy,
cells were fixed with 2.5% glutaraldehyde in 0.1M cacodylate buffer pH 7.4
for 45min at 4 uC, rinsed in cacodylate buffer, postfixed in 1% OsO4 in cacody-
late buffer, dehydrated and embedded in Epon. Ultrathin sections were briefly
contrasted with uranyl acetate and photographed with a Zeiss EM900 electron
microscope.
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
Chromosomal localization. For chromosomal localization of the gene-trap
insertion site, chromosomal slides were prepared from mouse spleen lympho-
cytes and hybridized with a biotinylated 2.7-kilobase (kb) cDNA insert as
described in ref. 31.
Characterization of the Ambra1gt mutation. Several subsequent rounds of
59PCR with reverse transcription and cDNA library screenings were performed
to obtain the 4,635 base pairs (bp) of compiled cDNA sequence. In detail, after
anchored (59 rapid amplification of cDNA ends) PCR (ref. 32), the cDNA tem-
plate obtained from embryonic stem cell mRNA was amplified by two sub-
sequent rounds of nested PCR. Primers were derived from the lacZ sequence.
The amplified products were then blotted and hybridized with a probe specific
for the vector splice acceptor site. Once isolated, the corresponding fragmentwas
used as a probe to screen an embryonicmouse cDNA library. After identification
of the corresponding cDNA in the databases, the insertion site was localized in
the largest 50.36-kb intron located between the 100- and 113-bp coding exons, as
shown in Supplementary Fig. 1b. The vector insertion disrupted the protein at
amino acid position 841 (sequence Mus musculus BAE33303.1), thus deleting
459 amino acids from the C-terminal end. For Ambra1 mRNA analysis,
poly(A)1 RNA was prepared from embryos and 2mg were analysed by standard
northern blot analysis.
The construct Ambra1gt, encoding the Ambra1–LacZ fusion protein present
in the gene-trap line, was generated as follows. Briefly, a construct containing the
sequences encoding the N-terminal part of the murine Ambra1 protein as pre-
sent in the gene-trap line (PCR form cDNA clone IMAGE:5400613) was inserted
in-frame within a LacZ–pA (LacZ-polyadenylation site) vector. Next, the
Ambra1–LacZ–pA fragment (6.1 kb) was isolated by SmaI–NotI digestion and
cloned into the SmaI–NotI cut pCMVSport 6 vector (GermanGenomeResource
Centre, RZPD) in the sense orientation. To check whether the Ambra1gt con-
struct was able to generate the expected Ambra1–LacZ fusion protein in an
eukaryotic cell line, we transfected it into the HEK293 cell line using the calcium
phosphate method. Cells were fixed and stained for b-gal activity 24 h after
transfection. Blue staining was already visible after 2 h. Positive and negative
control plasmids were also included in the assay, producing the expected results.
The full-length murine Ambra1 clone (Ambra1wt), used as a positive control,
contained the entire coding sequence inserted into the pCMV Sport 6 vector in
sense orientation.
Determination of genotype of Ambra1 mutant embryos. To genotype
embryos, a Southern blot analysis was performed after digestion of genomic
DNA with the BamHI restriction enzyme. The blots were incubated with
radioactive probes specific for lacZ and for the housekeeping Fkh5 gene.
Densitometric comparison between the two signals was performed to discrim-
inate between heterozygous and homozygous embryos. Early-stage embryos
were genotyped by PCR with reverse transcription. Two pairs of primers
were used: first, 59-AACGCATTTATACCCAGTCCA-39 (primer A) and 59-
ACCATAACGTATCGGCCCATC-39 (primer B),mapping upstream and down-
stream of the gene-trap insertion site, respectively; and, second, primer A
together with 59-CCCAGTCACGACGTTGTAAAA-39 (primer C), the latter
one mapping on the lacZ reporter sequence.
Histological and immunocytochemical analyses.Whole-mount b-gal staining
of embryos at different embryonic stages was performed as described33. In
brief, once removed from the uterus, embryos were washed in PBS and fixed
in 4% paraformaldehyde (PFA) for 30min at 4 uC. After washing, they were
incubated at 30 uC in a staining solution containing 5-bromo-4-chloro-3-indo-
lyl-b-D-galactoside for up to 15 h. The stained embryos were then cut with a
vibratome into 60-mm-thick sections and were examined under a Zeiss Axioplan
microscope.
For GFP–LC3 detection ofAmbra1gt/gt;GFP–LC3 embryos, 10-mm-thick cryo-
stat sections were prepared and analysed under an Olympus IX70 microscope
using softWoRx and DeltaVision Imaging Workstation (Applied Precision).
Paraffin sectioning specimens were impregnated with paraffin wax (Paraplast
Plus), embedded, transversally sectioned at 10 mm, and counterstained with
cresyl-violet.
For immunohistochemical analysis, the Ambra1gt/gt and wild-type embryos at
E9–E9.5 were fixed in 4% PFA, washed and incubated in 25% sucrose, before
cryo-embedding. Sagittal and coronal 10-mm-thick sections were blocked in 5%
horse serum and then incubated overnight with the primary antibodies.
Fluorescent secondary antibodies (Molecular Probes) were used for signal detec-
tion. Cellular nuclei were counterstained with 4,6-diamidino-2-phenylindole or
propidium iodide (Molecular Probes). Sections were then examined under an
inverted fluorescence microscope (Nikon and Leica). For ubiquitin detection, a
biotinylated goat anti-mouse IgG was used as a secondary antibody followed by
incubation with horseradish peroxidase-conjugated streptavidin (Biogenex).
The immunoreaction product was revealed using 3-amino-9-ethyl-carbazole
as a chromogenic substrate and 0.01% H2O2 (Biogenex). In cell death experi-
ments, apoptotic cells in embryonic sections were detected by a DNA fragmenta-
tion (TUNEL) assay using a fluorescein-based detection kit (Promega). Analysis
of cell proliferation was performed after intraperitoneal injection of BrdU
(Sigma–Aldrich) using an anti-BrdU antibody (Amersham). For confocal ana-
lysis of Becn1–Ambra1 co-localization andGFP–LC3-transduction experiments,
cells were cultured on coverslips and fixed with 4% PFA in PBS followed by
permeabilization with 0.1% Triton X-100 in PBS. Primary antibodies were incu-
bated for 1 h at room temperature and visualized by means of Cy3- or Cy2-
conjugated secondary antibodies (Jackson ImmunoResearch). Coverslips were
mounted in Vectashield (Vector Laboratories) and examined under a confocal
microscope (Leica TCS SP2).
Antibodies. The primary antibodies used in this study were: rabbit polyclonal
anti-Myc Tag antibody (Upstate Biotechnology), goat polyclonal anti-Becn1
(Santa Cruz), mouse monoclonal anti-Becn1 (Becton–Dickinson), rabbit poly-
clonal anti-Vps34 (Invitrogen), rabbit polyclonal anti-phospho-p70S6K (Cell
Signaling), mouse monoclonal anti-tubulin (Sigma–Aldrich), rabbit polyclonal
anti-LC3 (MBL), mouse monoclonal anti b-gal (Promega), rabbit polyclonal
anti-Shh (Santa Cruz) and mouse monoclonal anti-ubiquitin (1B3, MBL). The
antibody against Ambra1 was raised by immunizing rabbits with a peptide
located at the amino-terminal of Ambra1 protein (WEGKRVELPDSPRSC)
(Sigma Genosys) and was affinity-purified using the immunizing peptide.
Yeast two-hybrid screening. pGBKT7–AMBRA1 was generated by cloning the
N-terminal region (nucleotides 1–2,001) of AMBRA1 into the EcoRI and BglII
sites of pGBKT7 (Clontech). A human brain cDNA library cloned in pACT2
(Clontech) was screened by co-transformation with the pGBKT7–AMBRA1
into the AH109 yeast strain. Positive clones were selected based on their
growth on Trp, Leu, Ade and His dropout media (Clontech) containing 5mM
3-amino-1,2,4-triazole (Sigma–Aldrich). Recovery of the plasmids and the b-gal
assay was performed following the manufacturer’s instructions (Matchmaker
Two-Hybrid System Protocol, Clontech).
Cell culture. The human fibrosarcoma 2FTGH cell line, provided by S.
Pellegrini, and the human embryonic kidney HEK293 cells, provided by M.
Pando, were cultured in DMEM (Sigma–Aldrich) supplemented with 10%
FCS (Sigma–Aldrich), 2mM L-glutamine, and 1% penicillin/streptomycin solu-
tion at 37 uC under 5% CO2. For autophagy induction, cells were treated with
2 mM rapamycin (Sigma-Aldrich) or cultured in Earle’s balanced salt solution.
MEF primary cells were prepared from E13.5 embryos, cultured in DMEM
supplemented with 20% FCS, and utilized for experiments between the second
and the seventh passages.
RNA interference. siRNA oligoribonucleotides corresponding to the human
AMBRA1 and BECN1 cDNA sequences were purchased from Dharmacon
(AMBRA1) and Invitrogen (BECN1, BECN1 Stealth Select RNAi;
HSS112742). AMBRA1 siRNA 1: 59-AGAACTGCAAGATCTACAA-3;
AMBRA1 siRNA 2: 59-GGCCTATGGTACTAACAAA-39.
A total of 23 105 cells per well were transfected with 100 pmol siRNA in six-
well plates by Lipofectamine 2,000 (Invitrogen), as indicated by the supplier.
Transfection was repeated on two consecutive days to increase transfection
efficiency. Twenty-four hours after transfection, cells were digested with trypsin,
plated at 53 104 cells per well in six-well plates and treated with rapamycin
(Sigma–Aldrich). The RNA decrease was checked by real-time PCR and western
blot 48 h after transfection.
Cell proliferation analysis. To measure the percentage of cells entering in S
phase, BrdU was added to a final concentration of 20 mM and incubated at
37 uC for 20min. Cells were detached using trypsin, washed with PBS and fixed
using cold 70% ethanol. DNA was denaturated by adding 4N HCl for 1 h at
room temperature, followed by neutralization with 0.5M Na2B4O7 (pH 8.5).
Cells were then incubated with anti-BrdU Alexa Fluor 488 (0.2mgml–1,
Molecular Probes) in PBS plus 0.5% Tween 20 for 1 h at 37 uC. Finally, cells were
washed with PBS, resuspended in PBS plus 5mgml–1 propidium iodide and ana-
lysed using a FACScan flow cytometer (Becton Dickinson).
cDNA cloning and retroviral vectors. For retroviral expression, all constructs
were cloned in a modified version of pLPCX vector (Clontech) in which the SalI
restriction site within the puromycin-resistance gene was mutated by PCR to
render the SalI site unique in the multiple cloning site. An additional cyto-
megalovirus promoter was cloned in front of the 59 long terminal repeat region
to increase viral production34.
Human AMBRA1 cDNA (Supplementary Fig. 1c) was obtained by PCR amp-
lification from a human brain cDNA library (Clontech) and cloned in EcoRI and
NotI sites of the pLPCX vector. The various pCLPCX–AMBRA1 mutants (NT,
CT, F1, F2, F3, F4 and F5) were generated by PCR amplification using specific
primers. Myc-tagged AMBRA1 fusion proteins were obtained by inserting five
copies of the Myc epitope in the HindIII–EcoRI restriction sites of pLPCX.
Human BECN1 cDNA was obtained by PCR amplification from a HeLa
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cDNA library (Clontech) and cloned into the EcoRI and SalI sites of pCLPCX.
Human LC3 cDNA was obtained by PCR amplification from a HeLa cDNA
library (Clontech) and inserted into the EcoRI and SalI sites of pEGFP/C2
(Clontech). GFP–LC3 fusion cDNA was then excised from the pEGFP plasmid
by cutting with NheI and SalI restriction enzymes and inserted into pLPCX
digested with EcoRI and SalI, with NheI and EcoRI DNA ends blunted to allow
the ligation. pLPCX-lacZ-myc was obtained by digesting the pcDNA 3.1 myc-
His/lacZ plasmid (Invitrogen) with HindIII–PmeI and inserted into pLPCX
digested with HindIII–NotI (blunted). Human p40(phox)PX cDNA (encoding
amino acids 13–140 of human p40phox protein) was obtained by PCR amp-
lification from aHeLa cDNA library (Clontech), inserted into the EcoRI and SalI
sites of pEGFP/C2 (Clontech) and transfected into theHEK293 cell line using the
calcium phosphate method. The sequences of all PCR-amplified cDNAs were
verified by DNA sequencing analysis.
Retrovirus generation and infection. Fifteen micrograms of the retroviral vec-
tors were co-transfected with 5mg of an expression plasmid for the vesicular
stomatitis virus G protein into the cell line 293 gp/bsr (ref. 35) using the calcium
phosphate method. Forty-either hours later, the supernatant containing the
retroviral particles was recovered and supplemented with polybrene (4mgml–1).
2FTGH or MEF cells were infected by incubation with retroviral-containing
supernantant for 6–8 h.
Real-time PCR. RNA was prepared with Trizol reagent (Invitrogen). cDNA
synthesis was generated using the reverse transcription kit (Promega) according
to manufacturer’s recommendations. Real-time PCR reactions were performed
with the LightCycler (Roche). The LightCycler FastStart DNA Master SYBR
Green I (Roche) was used to produce fluorescent-labelled PCR products during
repetitive cycling of the amplification reaction. Primer sets for all ampliconswere
designed using the Primer-Express 1.0 software system. AMBRA1 forward: 59-
AACCCTCCACTGCGAGTTGA-39; AMBRA1 reverse: 59-TCTACCTGTTCC-
GTGGTTCTCC-39; L34 forward: 59-GTCCCGAACCCCTGGTAATAGA-39;
L34 reverse: 59-GGCCCTGCTGACATGTTTCTT-39.
The result of the fluorescent PCR was expressed as the threshold cycle (CT).
The DCT is the difference between the CT for a specific mRNA and the CT for a
reference mRNA, L34. To determine relative mRNA levels, 2 was raised to the
power of DDCT (the difference between the DCT from treated cells and the CT
from untreated cells). L34 mRNA level was used as an internal control because
this gene was shown to be stable with cell induction. b-actin and glyceraldehyde-
3-phosphate dehydrogenase levels were used as additional controls to confirm
significant decreases.
Immunoprecipitation and western blot assays. In immunoprecipitation
experiments, cells or tissues were lysed in HEMG buffer (25mM HEPES
(pH8.0), 100mMNaCl, 0.5%Nonidet P-40, 0.1mM EDTA, 10% glycerol) plus
protease and phosphatase inhibitors (protease inhibitor cocktail, 1mM sodium
fluoride, 1mM sodium orthovanadate, 1mM sodium molibdate; Sigma–
Aldrich). Lysates (1–2mg) were then incubated with rotation at 4 uC for
30min. After a centrifugation at 4 uC for 10min at 13,000g to remove insoluble
debris, equal amounts of protein were incubated with 30ml monoclonal anti-
cMyc antibody conjugated with protein A agarose beads (BD Biosciences) with
rotation at 4 uC for 4 h, or with 2 mg of BECN1 or AMBRA1 antibodies overnight
at 4 uC, followed by 60min incubationwith 20 ml of protein A/G sepharose beads
(Amersham Bioscience). The beads were finally collected by centrifugation and
washed four times with the HEMG buffer. Proteins bound to the beads were
eluted with 50 ml of SDS–polyacrylamide gel electrophoresis sample buffer and
heated to 70 uC for 10min.
Proteins were separated on NuPAGE Bis-Tris gel (Invitrogen) and electro-
blotted onto nitrocellulose membranes (Protran, Schleicher and Schuell). Blots
were incubatedwith primary antibodies in 5%non-fat drymilk in PBS plus 0.1%
Tween 20 overnight at 4 uC. Detection was achieved using horseradish peroxi-
dase-conjugate secondary antibody (Jackson Laboratory) and visualized with
ECL plus (Amersham Bioscience).
Embryos from stage E11–E11.5 to E14–E14.5 were subjected to mechanical
lysis in 50mM Tris HCl (pH7.5), 320mM sucrose, 50mM NaCl, 1% Triton
X-100 and protease inhibitors. Solubilized proteins were quantified by a Biorad
protein assay, and denatured by adding a concentrated boiling Laemmli buffer. A
total of 30–50mg of protein was analysed by SDS–polyacrylamide gel electro-
phoresis and immunoblotting.
Statistical analysis. Microsoft Excel was used for statistical analysis. Statistical
significance was determined using the Student’s t-test. A P value of less than or
equal to 0.05 was considered significant.
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